Global Next-Generation Oncology Solution Supply, Demand and Key Producers, 2023-2029
The global Next-Generation Oncology Solution market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Next-Generation Oncology Solution demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Next-Generation Oncology Solution, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Next-Generation Oncology Solution that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Next-Generation Oncology Solution total market, 2018-2029, (USD Million)
Global Next-Generation Oncology Solution total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Next-Generation Oncology Solution total market, key domestic companies and share, (USD Million)
Global Next-Generation Oncology Solution revenue by player and market share 2018-2023, (USD Million)
Global Next-Generation Oncology Solution total market by Type, CAGR, 2018-2029, (USD Million)
Global Next-Generation Oncology Solution total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Next-Generation Oncology Solution market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, PerkinElmer, Thermo Fisher Scientific, Roche Holding, Agilent Technologies, Paige, GE Healthcare, Varian and Brainlab, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Next-Generation Oncology Solution market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Next-Generation Oncology Solution Market, By Region:
1. How big is the global Next-Generation Oncology Solution market?
2. What is the demand of the global Next-Generation Oncology Solution market?
3. What is the year over year growth of the global Next-Generation Oncology Solution market?
4. What is the total value of the global Next-Generation Oncology Solution market?
5. Who are the major players in the global Next-Generation Oncology Solution market?
6. What are the growth factors driving the market demand?
This report studies the global Next-Generation Oncology Solution demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Next-Generation Oncology Solution, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Next-Generation Oncology Solution that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Next-Generation Oncology Solution total market, 2018-2029, (USD Million)
Global Next-Generation Oncology Solution total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Next-Generation Oncology Solution total market, key domestic companies and share, (USD Million)
Global Next-Generation Oncology Solution revenue by player and market share 2018-2023, (USD Million)
Global Next-Generation Oncology Solution total market by Type, CAGR, 2018-2029, (USD Million)
Global Next-Generation Oncology Solution total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Next-Generation Oncology Solution market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, PerkinElmer, Thermo Fisher Scientific, Roche Holding, Agilent Technologies, Paige, GE Healthcare, Varian and Brainlab, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Next-Generation Oncology Solution market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Next-Generation Oncology Solution Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy)
- Software
- Others
- Hospitals
- Diagnostic Imaging Centers
- Others
- Illumina
- PerkinElmer
- Thermo Fisher Scientific
- Roche Holding
- Agilent Technologies
- Paige
- GE Healthcare
- Varian
- Brainlab
- Qiagen
- Hologic
- Pacific Biosciences
- AstraZeneca
- BGI Group
1. How big is the global Next-Generation Oncology Solution market?
2. What is the demand of the global Next-Generation Oncology Solution market?
3. What is the year over year growth of the global Next-Generation Oncology Solution market?
4. What is the total value of the global Next-Generation Oncology Solution market?
5. Who are the major players in the global Next-Generation Oncology Solution market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Next-Generation Oncology Solution Introduction
1.2 World Next-Generation Oncology Solution Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Next-Generation Oncology Solution Total Market by Region (by Headquarter Location)
1.3.1 World Next-Generation Oncology Solution Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Next-Generation Oncology Solution Market Size (2018-2029)
1.3.3 China Next-Generation Oncology Solution Market Size (2018-2029)
1.3.4 Europe Next-Generation Oncology Solution Market Size (2018-2029)
1.3.5 Japan Next-Generation Oncology Solution Market Size (2018-2029)
1.3.6 South Korea Next-Generation Oncology Solution Market Size (2018-2029)
1.3.7 ASEAN Next-Generation Oncology Solution Market Size (2018-2029)
1.3.8 India Next-Generation Oncology Solution Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Next-Generation Oncology Solution Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Next-Generation Oncology Solution Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Next-Generation Oncology Solution Consumption Value (2018-2029)
2.2 World Next-Generation Oncology Solution Consumption Value by Region
2.2.1 World Next-Generation Oncology Solution Consumption Value by Region (2018-2023)
2.2.2 World Next-Generation Oncology Solution Consumption Value Forecast by Region (2024-2029)
2.3 United States Next-Generation Oncology Solution Consumption Value (2018-2029)
2.4 China Next-Generation Oncology Solution Consumption Value (2018-2029)
2.5 Europe Next-Generation Oncology Solution Consumption Value (2018-2029)
2.6 Japan Next-Generation Oncology Solution Consumption Value (2018-2029)
2.7 South Korea Next-Generation Oncology Solution Consumption Value (2018-2029)
2.8 ASEAN Next-Generation Oncology Solution Consumption Value (2018-2029)
2.9 India Next-Generation Oncology Solution Consumption Value (2018-2029)
3 WORLD NEXT-GENERATION ONCOLOGY SOLUTION COMPANIES COMPETITIVE ANALYSIS
3.1 World Next-Generation Oncology Solution Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Next-Generation Oncology Solution Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Next-Generation Oncology Solution in 2022
3.2.3 Global Concentration Ratios (CR8) for Next-Generation Oncology Solution in 2022
3.3 Next-Generation Oncology Solution Company Evaluation Quadrant
3.4 Next-Generation Oncology Solution Market: Overall Company Footprint Analysis
3.4.1 Next-Generation Oncology Solution Market: Region Footprint
3.4.2 Next-Generation Oncology Solution Market: Company Product Type Footprint
3.4.3 Next-Generation Oncology Solution Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Next-Generation Oncology Solution Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Next-Generation Oncology Solution Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Next-Generation Oncology Solution Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Next-Generation Oncology Solution Consumption Value Comparison
4.2.1 United States VS China: Next-Generation Oncology Solution Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Next-Generation Oncology Solution Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Next-Generation Oncology Solution Companies and Market Share, 2018-2023
4.3.1 United States Based Next-Generation Oncology Solution Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Next-Generation Oncology Solution Revenue, (2018-2023)
4.4 China Based Companies Next-Generation Oncology Solution Revenue and Market Share, 2018-2023
4.4.1 China Based Next-Generation Oncology Solution Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Next-Generation Oncology Solution Revenue, (2018-2023)
4.5 Rest of World Based Next-Generation Oncology Solution Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Next-Generation Oncology Solution Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Next-Generation Oncology Solution Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Next-Generation Oncology Solution Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy)
5.2.2 Software
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Next-Generation Oncology Solution Market Size by Type (2018-2023)
5.3.2 World Next-Generation Oncology Solution Market Size by Type (2024-2029)
5.3.3 World Next-Generation Oncology Solution Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Next-Generation Oncology Solution Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Diagnostic Imaging Centers
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Next-Generation Oncology Solution Market Size by Application (2018-2023)
6.3.2 World Next-Generation Oncology Solution Market Size by Application (2024-2029)
6.3.3 World Next-Generation Oncology Solution Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Illumina
7.1.1 Illumina Details
7.1.2 Illumina Major Business
7.1.3 Illumina Next-Generation Oncology Solution Product and Services
7.1.4 Illumina Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Illumina Recent Developments/Updates
7.1.6 Illumina Competitive Strengths & Weaknesses
7.2 PerkinElmer
7.2.1 PerkinElmer Details
7.2.2 PerkinElmer Major Business
7.2.3 PerkinElmer Next-Generation Oncology Solution Product and Services
7.2.4 PerkinElmer Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 PerkinElmer Recent Developments/Updates
7.2.6 PerkinElmer Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Details
7.3.2 Thermo Fisher Scientific Major Business
7.3.3 Thermo Fisher Scientific Next-Generation Oncology Solution Product and Services
7.3.4 Thermo Fisher Scientific Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Thermo Fisher Scientific Recent Developments/Updates
7.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.4 Roche Holding
7.4.1 Roche Holding Details
7.4.2 Roche Holding Major Business
7.4.3 Roche Holding Next-Generation Oncology Solution Product and Services
7.4.4 Roche Holding Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Roche Holding Recent Developments/Updates
7.4.6 Roche Holding Competitive Strengths & Weaknesses
7.5 Agilent Technologies
7.5.1 Agilent Technologies Details
7.5.2 Agilent Technologies Major Business
7.5.3 Agilent Technologies Next-Generation Oncology Solution Product and Services
7.5.4 Agilent Technologies Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Agilent Technologies Recent Developments/Updates
7.5.6 Agilent Technologies Competitive Strengths & Weaknesses
7.6 Paige
7.6.1 Paige Details
7.6.2 Paige Major Business
7.6.3 Paige Next-Generation Oncology Solution Product and Services
7.6.4 Paige Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Paige Recent Developments/Updates
7.6.6 Paige Competitive Strengths & Weaknesses
7.7 GE Healthcare
7.7.1 GE Healthcare Details
7.7.2 GE Healthcare Major Business
7.7.3 GE Healthcare Next-Generation Oncology Solution Product and Services
7.7.4 GE Healthcare Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 GE Healthcare Recent Developments/Updates
7.7.6 GE Healthcare Competitive Strengths & Weaknesses
7.8 Varian
7.8.1 Varian Details
7.8.2 Varian Major Business
7.8.3 Varian Next-Generation Oncology Solution Product and Services
7.8.4 Varian Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Varian Recent Developments/Updates
7.8.6 Varian Competitive Strengths & Weaknesses
7.9 Brainlab
7.9.1 Brainlab Details
7.9.2 Brainlab Major Business
7.9.3 Brainlab Next-Generation Oncology Solution Product and Services
7.9.4 Brainlab Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Brainlab Recent Developments/Updates
7.9.6 Brainlab Competitive Strengths & Weaknesses
7.10 Qiagen
7.10.1 Qiagen Details
7.10.2 Qiagen Major Business
7.10.3 Qiagen Next-Generation Oncology Solution Product and Services
7.10.4 Qiagen Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Qiagen Recent Developments/Updates
7.10.6 Qiagen Competitive Strengths & Weaknesses
7.11 Hologic
7.11.1 Hologic Details
7.11.2 Hologic Major Business
7.11.3 Hologic Next-Generation Oncology Solution Product and Services
7.11.4 Hologic Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Hologic Recent Developments/Updates
7.11.6 Hologic Competitive Strengths & Weaknesses
7.12 Pacific Biosciences
7.12.1 Pacific Biosciences Details
7.12.2 Pacific Biosciences Major Business
7.12.3 Pacific Biosciences Next-Generation Oncology Solution Product and Services
7.12.4 Pacific Biosciences Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Pacific Biosciences Recent Developments/Updates
7.12.6 Pacific Biosciences Competitive Strengths & Weaknesses
7.13 AstraZeneca
7.13.1 AstraZeneca Details
7.13.2 AstraZeneca Major Business
7.13.3 AstraZeneca Next-Generation Oncology Solution Product and Services
7.13.4 AstraZeneca Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 AstraZeneca Recent Developments/Updates
7.13.6 AstraZeneca Competitive Strengths & Weaknesses
7.14 BGI Group
7.14.1 BGI Group Details
7.14.2 BGI Group Major Business
7.14.3 BGI Group Next-Generation Oncology Solution Product and Services
7.14.4 BGI Group Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 BGI Group Recent Developments/Updates
7.14.6 BGI Group Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Next-Generation Oncology Solution Industry Chain
8.2 Next-Generation Oncology Solution Upstream Analysis
8.3 Next-Generation Oncology Solution Midstream Analysis
8.4 Next-Generation Oncology Solution Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Next-Generation Oncology Solution Introduction
1.2 World Next-Generation Oncology Solution Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Next-Generation Oncology Solution Total Market by Region (by Headquarter Location)
1.3.1 World Next-Generation Oncology Solution Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Next-Generation Oncology Solution Market Size (2018-2029)
1.3.3 China Next-Generation Oncology Solution Market Size (2018-2029)
1.3.4 Europe Next-Generation Oncology Solution Market Size (2018-2029)
1.3.5 Japan Next-Generation Oncology Solution Market Size (2018-2029)
1.3.6 South Korea Next-Generation Oncology Solution Market Size (2018-2029)
1.3.7 ASEAN Next-Generation Oncology Solution Market Size (2018-2029)
1.3.8 India Next-Generation Oncology Solution Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Next-Generation Oncology Solution Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Next-Generation Oncology Solution Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Next-Generation Oncology Solution Consumption Value (2018-2029)
2.2 World Next-Generation Oncology Solution Consumption Value by Region
2.2.1 World Next-Generation Oncology Solution Consumption Value by Region (2018-2023)
2.2.2 World Next-Generation Oncology Solution Consumption Value Forecast by Region (2024-2029)
2.3 United States Next-Generation Oncology Solution Consumption Value (2018-2029)
2.4 China Next-Generation Oncology Solution Consumption Value (2018-2029)
2.5 Europe Next-Generation Oncology Solution Consumption Value (2018-2029)
2.6 Japan Next-Generation Oncology Solution Consumption Value (2018-2029)
2.7 South Korea Next-Generation Oncology Solution Consumption Value (2018-2029)
2.8 ASEAN Next-Generation Oncology Solution Consumption Value (2018-2029)
2.9 India Next-Generation Oncology Solution Consumption Value (2018-2029)
3 WORLD NEXT-GENERATION ONCOLOGY SOLUTION COMPANIES COMPETITIVE ANALYSIS
3.1 World Next-Generation Oncology Solution Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Next-Generation Oncology Solution Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Next-Generation Oncology Solution in 2022
3.2.3 Global Concentration Ratios (CR8) for Next-Generation Oncology Solution in 2022
3.3 Next-Generation Oncology Solution Company Evaluation Quadrant
3.4 Next-Generation Oncology Solution Market: Overall Company Footprint Analysis
3.4.1 Next-Generation Oncology Solution Market: Region Footprint
3.4.2 Next-Generation Oncology Solution Market: Company Product Type Footprint
3.4.3 Next-Generation Oncology Solution Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Next-Generation Oncology Solution Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Next-Generation Oncology Solution Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Next-Generation Oncology Solution Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Next-Generation Oncology Solution Consumption Value Comparison
4.2.1 United States VS China: Next-Generation Oncology Solution Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Next-Generation Oncology Solution Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Next-Generation Oncology Solution Companies and Market Share, 2018-2023
4.3.1 United States Based Next-Generation Oncology Solution Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Next-Generation Oncology Solution Revenue, (2018-2023)
4.4 China Based Companies Next-Generation Oncology Solution Revenue and Market Share, 2018-2023
4.4.1 China Based Next-Generation Oncology Solution Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Next-Generation Oncology Solution Revenue, (2018-2023)
4.5 Rest of World Based Next-Generation Oncology Solution Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Next-Generation Oncology Solution Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Next-Generation Oncology Solution Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Next-Generation Oncology Solution Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy)
5.2.2 Software
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Next-Generation Oncology Solution Market Size by Type (2018-2023)
5.3.2 World Next-Generation Oncology Solution Market Size by Type (2024-2029)
5.3.3 World Next-Generation Oncology Solution Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Next-Generation Oncology Solution Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Diagnostic Imaging Centers
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Next-Generation Oncology Solution Market Size by Application (2018-2023)
6.3.2 World Next-Generation Oncology Solution Market Size by Application (2024-2029)
6.3.3 World Next-Generation Oncology Solution Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Illumina
7.1.1 Illumina Details
7.1.2 Illumina Major Business
7.1.3 Illumina Next-Generation Oncology Solution Product and Services
7.1.4 Illumina Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Illumina Recent Developments/Updates
7.1.6 Illumina Competitive Strengths & Weaknesses
7.2 PerkinElmer
7.2.1 PerkinElmer Details
7.2.2 PerkinElmer Major Business
7.2.3 PerkinElmer Next-Generation Oncology Solution Product and Services
7.2.4 PerkinElmer Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 PerkinElmer Recent Developments/Updates
7.2.6 PerkinElmer Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Details
7.3.2 Thermo Fisher Scientific Major Business
7.3.3 Thermo Fisher Scientific Next-Generation Oncology Solution Product and Services
7.3.4 Thermo Fisher Scientific Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Thermo Fisher Scientific Recent Developments/Updates
7.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.4 Roche Holding
7.4.1 Roche Holding Details
7.4.2 Roche Holding Major Business
7.4.3 Roche Holding Next-Generation Oncology Solution Product and Services
7.4.4 Roche Holding Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Roche Holding Recent Developments/Updates
7.4.6 Roche Holding Competitive Strengths & Weaknesses
7.5 Agilent Technologies
7.5.1 Agilent Technologies Details
7.5.2 Agilent Technologies Major Business
7.5.3 Agilent Technologies Next-Generation Oncology Solution Product and Services
7.5.4 Agilent Technologies Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Agilent Technologies Recent Developments/Updates
7.5.6 Agilent Technologies Competitive Strengths & Weaknesses
7.6 Paige
7.6.1 Paige Details
7.6.2 Paige Major Business
7.6.3 Paige Next-Generation Oncology Solution Product and Services
7.6.4 Paige Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Paige Recent Developments/Updates
7.6.6 Paige Competitive Strengths & Weaknesses
7.7 GE Healthcare
7.7.1 GE Healthcare Details
7.7.2 GE Healthcare Major Business
7.7.3 GE Healthcare Next-Generation Oncology Solution Product and Services
7.7.4 GE Healthcare Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 GE Healthcare Recent Developments/Updates
7.7.6 GE Healthcare Competitive Strengths & Weaknesses
7.8 Varian
7.8.1 Varian Details
7.8.2 Varian Major Business
7.8.3 Varian Next-Generation Oncology Solution Product and Services
7.8.4 Varian Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Varian Recent Developments/Updates
7.8.6 Varian Competitive Strengths & Weaknesses
7.9 Brainlab
7.9.1 Brainlab Details
7.9.2 Brainlab Major Business
7.9.3 Brainlab Next-Generation Oncology Solution Product and Services
7.9.4 Brainlab Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Brainlab Recent Developments/Updates
7.9.6 Brainlab Competitive Strengths & Weaknesses
7.10 Qiagen
7.10.1 Qiagen Details
7.10.2 Qiagen Major Business
7.10.3 Qiagen Next-Generation Oncology Solution Product and Services
7.10.4 Qiagen Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Qiagen Recent Developments/Updates
7.10.6 Qiagen Competitive Strengths & Weaknesses
7.11 Hologic
7.11.1 Hologic Details
7.11.2 Hologic Major Business
7.11.3 Hologic Next-Generation Oncology Solution Product and Services
7.11.4 Hologic Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Hologic Recent Developments/Updates
7.11.6 Hologic Competitive Strengths & Weaknesses
7.12 Pacific Biosciences
7.12.1 Pacific Biosciences Details
7.12.2 Pacific Biosciences Major Business
7.12.3 Pacific Biosciences Next-Generation Oncology Solution Product and Services
7.12.4 Pacific Biosciences Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Pacific Biosciences Recent Developments/Updates
7.12.6 Pacific Biosciences Competitive Strengths & Weaknesses
7.13 AstraZeneca
7.13.1 AstraZeneca Details
7.13.2 AstraZeneca Major Business
7.13.3 AstraZeneca Next-Generation Oncology Solution Product and Services
7.13.4 AstraZeneca Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 AstraZeneca Recent Developments/Updates
7.13.6 AstraZeneca Competitive Strengths & Weaknesses
7.14 BGI Group
7.14.1 BGI Group Details
7.14.2 BGI Group Major Business
7.14.3 BGI Group Next-Generation Oncology Solution Product and Services
7.14.4 BGI Group Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 BGI Group Recent Developments/Updates
7.14.6 BGI Group Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Next-Generation Oncology Solution Industry Chain
8.2 Next-Generation Oncology Solution Upstream Analysis
8.3 Next-Generation Oncology Solution Midstream Analysis
8.4 Next-Generation Oncology Solution Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Next-Generation Oncology Solution Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Next-Generation Oncology Solution Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Next-Generation Oncology Solution Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Next-Generation Oncology Solution Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Next-Generation Oncology Solution Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Next-Generation Oncology Solution Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Next-Generation Oncology Solution Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Next-Generation Oncology Solution Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Next-Generation Oncology Solution Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Next-Generation Oncology Solution Players in 2022
Table 12. World Next-Generation Oncology Solution Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Next-Generation Oncology Solution Company Evaluation Quadrant
Table 14. Head Office of Key Next-Generation Oncology Solution Player
Table 15. Next-Generation Oncology Solution Market: Company Product Type Footprint
Table 16. Next-Generation Oncology Solution Market: Company Product Application Footprint
Table 17. Next-Generation Oncology Solution Mergers & Acquisitions Activity
Table 18. United States VS China Next-Generation Oncology Solution Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Next-Generation Oncology Solution Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Next-Generation Oncology Solution Companies, Headquarters (States, Country)
Table 21. United States Based Companies Next-Generation Oncology Solution Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Next-Generation Oncology Solution Revenue Market Share (2018-2023)
Table 23. China Based Next-Generation Oncology Solution Companies, Headquarters (Province, Country)
Table 24. China Based Companies Next-Generation Oncology Solution Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Next-Generation Oncology Solution Revenue Market Share (2018-2023)
Table 26. Rest of World Based Next-Generation Oncology Solution Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Next-Generation Oncology Solution Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Next-Generation Oncology Solution Revenue Market Share (2018-2023)
Table 29. World Next-Generation Oncology Solution Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Next-Generation Oncology Solution Market Size by Type (2018-2023) & (USD Million)
Table 31. World Next-Generation Oncology Solution Market Size by Type (2024-2029) & (USD Million)
Table 32. World Next-Generation Oncology Solution Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Next-Generation Oncology Solution Market Size by Application (2018-2023) & (USD Million)
Table 34. World Next-Generation Oncology Solution Market Size by Application (2024-2029) & (USD Million)
Table 35. Illumina Basic Information, Area Served and Competitors
Table 36. Illumina Major Business
Table 37. Illumina Next-Generation Oncology Solution Product and Services
Table 38. Illumina Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Illumina Recent Developments/Updates
Table 40. Illumina Competitive Strengths & Weaknesses
Table 41. PerkinElmer Basic Information, Area Served and Competitors
Table 42. PerkinElmer Major Business
Table 43. PerkinElmer Next-Generation Oncology Solution Product and Services
Table 44. PerkinElmer Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. PerkinElmer Recent Developments/Updates
Table 46. PerkinElmer Competitive Strengths & Weaknesses
Table 47. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 48. Thermo Fisher Scientific Major Business
Table 49. Thermo Fisher Scientific Next-Generation Oncology Solution Product and Services
Table 50. Thermo Fisher Scientific Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Thermo Fisher Scientific Recent Developments/Updates
Table 52. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 53. Roche Holding Basic Information, Area Served and Competitors
Table 54. Roche Holding Major Business
Table 55. Roche Holding Next-Generation Oncology Solution Product and Services
Table 56. Roche Holding Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Roche Holding Recent Developments/Updates
Table 58. Roche Holding Competitive Strengths & Weaknesses
Table 59. Agilent Technologies Basic Information, Area Served and Competitors
Table 60. Agilent Technologies Major Business
Table 61. Agilent Technologies Next-Generation Oncology Solution Product and Services
Table 62. Agilent Technologies Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Agilent Technologies Recent Developments/Updates
Table 64. Agilent Technologies Competitive Strengths & Weaknesses
Table 65. Paige Basic Information, Area Served and Competitors
Table 66. Paige Major Business
Table 67. Paige Next-Generation Oncology Solution Product and Services
Table 68. Paige Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Paige Recent Developments/Updates
Table 70. Paige Competitive Strengths & Weaknesses
Table 71. GE Healthcare Basic Information, Area Served and Competitors
Table 72. GE Healthcare Major Business
Table 73. GE Healthcare Next-Generation Oncology Solution Product and Services
Table 74. GE Healthcare Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. GE Healthcare Recent Developments/Updates
Table 76. GE Healthcare Competitive Strengths & Weaknesses
Table 77. Varian Basic Information, Area Served and Competitors
Table 78. Varian Major Business
Table 79. Varian Next-Generation Oncology Solution Product and Services
Table 80. Varian Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Varian Recent Developments/Updates
Table 82. Varian Competitive Strengths & Weaknesses
Table 83. Brainlab Basic Information, Area Served and Competitors
Table 84. Brainlab Major Business
Table 85. Brainlab Next-Generation Oncology Solution Product and Services
Table 86. Brainlab Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Brainlab Recent Developments/Updates
Table 88. Brainlab Competitive Strengths & Weaknesses
Table 89. Qiagen Basic Information, Area Served and Competitors
Table 90. Qiagen Major Business
Table 91. Qiagen Next-Generation Oncology Solution Product and Services
Table 92. Qiagen Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Qiagen Recent Developments/Updates
Table 94. Qiagen Competitive Strengths & Weaknesses
Table 95. Hologic Basic Information, Area Served and Competitors
Table 96. Hologic Major Business
Table 97. Hologic Next-Generation Oncology Solution Product and Services
Table 98. Hologic Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Hologic Recent Developments/Updates
Table 100. Hologic Competitive Strengths & Weaknesses
Table 101. Pacific Biosciences Basic Information, Area Served and Competitors
Table 102. Pacific Biosciences Major Business
Table 103. Pacific Biosciences Next-Generation Oncology Solution Product and Services
Table 104. Pacific Biosciences Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Pacific Biosciences Recent Developments/Updates
Table 106. Pacific Biosciences Competitive Strengths & Weaknesses
Table 107. AstraZeneca Basic Information, Area Served and Competitors
Table 108. AstraZeneca Major Business
Table 109. AstraZeneca Next-Generation Oncology Solution Product and Services
Table 110. AstraZeneca Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. AstraZeneca Recent Developments/Updates
Table 112. BGI Group Basic Information, Area Served and Competitors
Table 113. BGI Group Major Business
Table 114. BGI Group Next-Generation Oncology Solution Product and Services
Table 115. BGI Group Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 116. Global Key Players of Next-Generation Oncology Solution Upstream (Raw Materials)
Table 117. Next-Generation Oncology Solution Typical Customers
Table 1. World Next-Generation Oncology Solution Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Next-Generation Oncology Solution Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Next-Generation Oncology Solution Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Next-Generation Oncology Solution Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Next-Generation Oncology Solution Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Next-Generation Oncology Solution Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Next-Generation Oncology Solution Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Next-Generation Oncology Solution Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Next-Generation Oncology Solution Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Next-Generation Oncology Solution Players in 2022
Table 12. World Next-Generation Oncology Solution Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Next-Generation Oncology Solution Company Evaluation Quadrant
Table 14. Head Office of Key Next-Generation Oncology Solution Player
Table 15. Next-Generation Oncology Solution Market: Company Product Type Footprint
Table 16. Next-Generation Oncology Solution Market: Company Product Application Footprint
Table 17. Next-Generation Oncology Solution Mergers & Acquisitions Activity
Table 18. United States VS China Next-Generation Oncology Solution Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Next-Generation Oncology Solution Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Next-Generation Oncology Solution Companies, Headquarters (States, Country)
Table 21. United States Based Companies Next-Generation Oncology Solution Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Next-Generation Oncology Solution Revenue Market Share (2018-2023)
Table 23. China Based Next-Generation Oncology Solution Companies, Headquarters (Province, Country)
Table 24. China Based Companies Next-Generation Oncology Solution Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Next-Generation Oncology Solution Revenue Market Share (2018-2023)
Table 26. Rest of World Based Next-Generation Oncology Solution Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Next-Generation Oncology Solution Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Next-Generation Oncology Solution Revenue Market Share (2018-2023)
Table 29. World Next-Generation Oncology Solution Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Next-Generation Oncology Solution Market Size by Type (2018-2023) & (USD Million)
Table 31. World Next-Generation Oncology Solution Market Size by Type (2024-2029) & (USD Million)
Table 32. World Next-Generation Oncology Solution Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Next-Generation Oncology Solution Market Size by Application (2018-2023) & (USD Million)
Table 34. World Next-Generation Oncology Solution Market Size by Application (2024-2029) & (USD Million)
Table 35. Illumina Basic Information, Area Served and Competitors
Table 36. Illumina Major Business
Table 37. Illumina Next-Generation Oncology Solution Product and Services
Table 38. Illumina Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Illumina Recent Developments/Updates
Table 40. Illumina Competitive Strengths & Weaknesses
Table 41. PerkinElmer Basic Information, Area Served and Competitors
Table 42. PerkinElmer Major Business
Table 43. PerkinElmer Next-Generation Oncology Solution Product and Services
Table 44. PerkinElmer Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. PerkinElmer Recent Developments/Updates
Table 46. PerkinElmer Competitive Strengths & Weaknesses
Table 47. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 48. Thermo Fisher Scientific Major Business
Table 49. Thermo Fisher Scientific Next-Generation Oncology Solution Product and Services
Table 50. Thermo Fisher Scientific Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Thermo Fisher Scientific Recent Developments/Updates
Table 52. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 53. Roche Holding Basic Information, Area Served and Competitors
Table 54. Roche Holding Major Business
Table 55. Roche Holding Next-Generation Oncology Solution Product and Services
Table 56. Roche Holding Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Roche Holding Recent Developments/Updates
Table 58. Roche Holding Competitive Strengths & Weaknesses
Table 59. Agilent Technologies Basic Information, Area Served and Competitors
Table 60. Agilent Technologies Major Business
Table 61. Agilent Technologies Next-Generation Oncology Solution Product and Services
Table 62. Agilent Technologies Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Agilent Technologies Recent Developments/Updates
Table 64. Agilent Technologies Competitive Strengths & Weaknesses
Table 65. Paige Basic Information, Area Served and Competitors
Table 66. Paige Major Business
Table 67. Paige Next-Generation Oncology Solution Product and Services
Table 68. Paige Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Paige Recent Developments/Updates
Table 70. Paige Competitive Strengths & Weaknesses
Table 71. GE Healthcare Basic Information, Area Served and Competitors
Table 72. GE Healthcare Major Business
Table 73. GE Healthcare Next-Generation Oncology Solution Product and Services
Table 74. GE Healthcare Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. GE Healthcare Recent Developments/Updates
Table 76. GE Healthcare Competitive Strengths & Weaknesses
Table 77. Varian Basic Information, Area Served and Competitors
Table 78. Varian Major Business
Table 79. Varian Next-Generation Oncology Solution Product and Services
Table 80. Varian Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Varian Recent Developments/Updates
Table 82. Varian Competitive Strengths & Weaknesses
Table 83. Brainlab Basic Information, Area Served and Competitors
Table 84. Brainlab Major Business
Table 85. Brainlab Next-Generation Oncology Solution Product and Services
Table 86. Brainlab Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Brainlab Recent Developments/Updates
Table 88. Brainlab Competitive Strengths & Weaknesses
Table 89. Qiagen Basic Information, Area Served and Competitors
Table 90. Qiagen Major Business
Table 91. Qiagen Next-Generation Oncology Solution Product and Services
Table 92. Qiagen Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Qiagen Recent Developments/Updates
Table 94. Qiagen Competitive Strengths & Weaknesses
Table 95. Hologic Basic Information, Area Served and Competitors
Table 96. Hologic Major Business
Table 97. Hologic Next-Generation Oncology Solution Product and Services
Table 98. Hologic Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Hologic Recent Developments/Updates
Table 100. Hologic Competitive Strengths & Weaknesses
Table 101. Pacific Biosciences Basic Information, Area Served and Competitors
Table 102. Pacific Biosciences Major Business
Table 103. Pacific Biosciences Next-Generation Oncology Solution Product and Services
Table 104. Pacific Biosciences Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Pacific Biosciences Recent Developments/Updates
Table 106. Pacific Biosciences Competitive Strengths & Weaknesses
Table 107. AstraZeneca Basic Information, Area Served and Competitors
Table 108. AstraZeneca Major Business
Table 109. AstraZeneca Next-Generation Oncology Solution Product and Services
Table 110. AstraZeneca Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. AstraZeneca Recent Developments/Updates
Table 112. BGI Group Basic Information, Area Served and Competitors
Table 113. BGI Group Major Business
Table 114. BGI Group Next-Generation Oncology Solution Product and Services
Table 115. BGI Group Next-Generation Oncology Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 116. Global Key Players of Next-Generation Oncology Solution Upstream (Raw Materials)
Table 117. Next-Generation Oncology Solution Typical Customers
LIST OF FIGURES
Figure 1. Next-Generation Oncology Solution Picture
Figure 2. World Next-Generation Oncology Solution Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Next-Generation Oncology Solution Total Market Size (2018-2029) & (USD Million)
Figure 4. World Next-Generation Oncology Solution Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Next-Generation Oncology Solution Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Next-Generation Oncology Solution Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Next-Generation Oncology Solution Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Next-Generation Oncology Solution Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Next-Generation Oncology Solution Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Next-Generation Oncology Solution Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Next-Generation Oncology Solution Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Next-Generation Oncology Solution Revenue (2018-2029) & (USD Million)
Figure 13. Next-Generation Oncology Solution Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Next-Generation Oncology Solution Consumption Value (2018-2029) & (USD Million)
Figure 16. World Next-Generation Oncology Solution Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Next-Generation Oncology Solution Consumption Value (2018-2029) & (USD Million)
Figure 18. China Next-Generation Oncology Solution Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Next-Generation Oncology Solution Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Next-Generation Oncology Solution Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Next-Generation Oncology Solution Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Next-Generation Oncology Solution Consumption Value (2018-2029) & (USD Million)
Figure 23. India Next-Generation Oncology Solution Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Next-Generation Oncology Solution by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Next-Generation Oncology Solution Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Next-Generation Oncology Solution Markets in 2022
Figure 27. United States VS China: Next-Generation Oncology Solution Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Next-Generation Oncology Solution Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Next-Generation Oncology Solution Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Next-Generation Oncology Solution Market Size Market Share by Type in 2022
Figure 31. Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy)
Figure 32. Software
Figure 33. Others
Figure 34. World Next-Generation Oncology Solution Market Size Market Share by Type (2018-2029)
Figure 35. World Next-Generation Oncology Solution Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Next-Generation Oncology Solution Market Size Market Share by Application in 2022
Figure 37. Hospitals
Figure 38. Diagnostic Imaging Centers
Figure 39. Others
Figure 40. Next-Generation Oncology Solution Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Figure 1. Next-Generation Oncology Solution Picture
Figure 2. World Next-Generation Oncology Solution Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Next-Generation Oncology Solution Total Market Size (2018-2029) & (USD Million)
Figure 4. World Next-Generation Oncology Solution Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Next-Generation Oncology Solution Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Next-Generation Oncology Solution Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Next-Generation Oncology Solution Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Next-Generation Oncology Solution Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Next-Generation Oncology Solution Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Next-Generation Oncology Solution Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Next-Generation Oncology Solution Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Next-Generation Oncology Solution Revenue (2018-2029) & (USD Million)
Figure 13. Next-Generation Oncology Solution Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Next-Generation Oncology Solution Consumption Value (2018-2029) & (USD Million)
Figure 16. World Next-Generation Oncology Solution Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Next-Generation Oncology Solution Consumption Value (2018-2029) & (USD Million)
Figure 18. China Next-Generation Oncology Solution Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Next-Generation Oncology Solution Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Next-Generation Oncology Solution Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Next-Generation Oncology Solution Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Next-Generation Oncology Solution Consumption Value (2018-2029) & (USD Million)
Figure 23. India Next-Generation Oncology Solution Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Next-Generation Oncology Solution by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Next-Generation Oncology Solution Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Next-Generation Oncology Solution Markets in 2022
Figure 27. United States VS China: Next-Generation Oncology Solution Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Next-Generation Oncology Solution Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Next-Generation Oncology Solution Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Next-Generation Oncology Solution Market Size Market Share by Type in 2022
Figure 31. Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy)
Figure 32. Software
Figure 33. Others
Figure 34. World Next-Generation Oncology Solution Market Size Market Share by Type (2018-2029)
Figure 35. World Next-Generation Oncology Solution Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Next-Generation Oncology Solution Market Size Market Share by Application in 2022
Figure 37. Hospitals
Figure 38. Diagnostic Imaging Centers
Figure 39. Others
Figure 40. Next-Generation Oncology Solution Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
